期刊文献+
共找到66篇文章
< 1 2 4 >
每页显示 20 50 100
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b- and c-related-hepatocellularcarcinoma 被引量:25
1
作者 Sirio Fiorino Maria Letizia Bacchi-Reggiani +17 位作者 Michela Visani Giorgia Acquaviva Adele Fornelli Michele Masetti Andrea Tura Fabio Grizzi Matteo Zanello Laura Mastrangelo Raffaele Lombardi Luca Di Tommaso Arrigo Bondi Sergio Sabbatani Andrea Domanico Carlo fabbri Paolo Leandri Annalisa Pession Elio Jovine Dario de Biase 《World Journal of Gastroenterology》 SCIE CAS 2016年第15期3907-3936,共30页
Aim of the present review is to summarize the current knowledge about the potential relationship between mi RNAs and hepatitis B virus(HBV)-hepatitis C virus(HCV) related liver diseases. A systematic computerbased sea... Aim of the present review is to summarize the current knowledge about the potential relationship between mi RNAs and hepatitis B virus(HBV)-hepatitis C virus(HCV) related liver diseases. A systematic computerbased search of published articles, according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Statement, was performed to identify relevant studies on usefulness of serum/plasma/urine mi RNAs, as noninvasive biomarkers for early detection of HBV and HCV-induced hepatocellular carcinoma(HCC) development, as well as for its prognostic evaluation. The used Medical Subject Headings terms and keywords were: "HBV", "HCV", "hepatocellular carcinoma", "micro RNAs", "mi RNAs", "diagnosis", "prognosis", "therapy", "treatment". Some serum/plasma mi RNAs, including mi R-21, mi R-122, mi-125a/b, mi R-199a/b, mi R-221, mi R-222, mi R-223, mi R-224 might serve as biomarkers for early diagnosis/prognosis of HCC, but, to date, not definitive results or well-defined panels of mi RNAs have been obtained. More well-designed studies, focusing on populations of different geographical areas and involving larger series of patients, should be carried out to improve our knowledge on the potential role of mi RNAs for HCC early detection and prognosis. 展开更多
关键词 HEPATITIS B VIRUS HEPATITIS C VIRUS HEPATOCELLULAR CARCINOMAS Liver DISEASES MICRORNAS Review
下载PDF
Endoscopic ultrasound-guided treatments: Are we getting evidence based- a systematic review 被引量:21
2
作者 Carlo fabbri Carmelo Luigiano +4 位作者 Andrea Lisotti Vincenzo Cennamo Clara Virgilio Giancarlo Caletti Pietro Fusaroli 《World Journal of Gastroenterology》 SCIE CAS 2014年第26期8424-8448,共25页
The continued need to develop less invasive alternatives to surgical and radiologic interventions has driven the development of endoscopic ultrasound(EUS)-guided treatments.These include EUS-guided drainage of pancrea... The continued need to develop less invasive alternatives to surgical and radiologic interventions has driven the development of endoscopic ultrasound(EUS)-guided treatments.These include EUS-guided drainage of pancreatic fluid collections,EUS-guided necrosectomy,EUS-guided cholangiography and biliary drainage,EUSguided pancreatography and pancreatic duct drainage,EUS-guided gallbladder drainage,EUS-guided drainage of abdominal and pelvic fluid collections,EUS-guided celiac plexus block and celiac plexus neurolysis,EUSguided pancreatic cyst ablation,EUS-guided vascular interventions,EUS-guided delivery of antitumoral agents and EUS-guided fiducial placement and brachytherapy.However these procedures are technically challenging and require expertise in both EUS and interventional endoscopy,such as endoscopic retrograde cholangiopancreatography and gastrointestinal stenting.We undertook a systematic review to record the entire body of literature accumulated over the past 2decades on EUS-guided interventions with the objective of performing a critical appraisal of published articles,based on the classification of studies according to levels of evidence,in order to assess the scientific progress made in this field. 展开更多
关键词 Endoscopic ultrasound Pseudocyst drainage NECROSECTOMY Celiac plexus neurolysis Levels of evidence Fine needle injection
下载PDF
中国明代木质古建西安鼓楼彩绘的分析研究 被引量:15
3
作者 Mazzeo R Cam D +3 位作者 Chiavari G fabbri D 和玲 Prati S 《文物保护与考古科学》 2005年第2期9-15,65,共7页
鉴于有关中国木质古建彩绘材料及技术的研究报道较少,本工作通过光学显微镜、扫描电镜能谱(SEMEDX)、X射线衍射及气相色谱质谱(GC/MS)分析方法,对建于公元1380年的中国西安明代鼓楼木建表面彩绘样品进行了科学检测研究,分析了其中的无... 鉴于有关中国木质古建彩绘材料及技术的研究报道较少,本工作通过光学显微镜、扫描电镜能谱(SEMEDX)、X射线衍射及气相色谱质谱(GC/MS)分析方法,对建于公元1380年的中国西安明代鼓楼木建表面彩绘样品进行了科学检测研究,分析了其中的无机材料组成及彩绘所用粘合剂,并收集了所涉及到的相关历史资料。分析结果表明,木建表面彩绘的材料组成和制作技术与历史调查获得的信息完全吻合。地仗层主要由粘土、石灰、干性油(桐油)及纤维织物组成,且地仗层保持最初的原材料。颜料分析结果显示,尽管修复时所使用的粘合剂与最初建造时的粘合剂完全相同,但目前彩绘的颜料即有原来使用的材料,也有十八世纪修复时所使用的材料。 展开更多
关键词 传统彩绘材料 古木质建筑 地仗 粘合剂
下载PDF
Endoscopic ultrasound-guided drainage of pancreatic fluid collections 被引量:14
4
作者 Carlo fabbri Carmelo Luigiano +3 位作者 Antonella Maimone Anna Maria Polifemo Ⅰlaria Tarantino Vincenzo Cennamo 《World Journal of Gastrointestinal Endoscopy》 CAS 2012年第11期479-488,共10页
Pancreatic fluid collections (PFCs) develop secondary to either fluid leakage or liquefaction of pancreatic necrosis following acute pancreatitis, chronic pancreatitis, surgery or abdominal trauma. Pancreatic fluid c... Pancreatic fluid collections (PFCs) develop secondary to either fluid leakage or liquefaction of pancreatic necrosis following acute pancreatitis, chronic pancreatitis, surgery or abdominal trauma. Pancreatic fluid collections include acute fluid collections, acute and chronic pancreatic pseudocysts, pancreatic abscesses and pancreatic necrosis. Before the introduction of linear endoscopic ultrasound (EUS) in the 1990s and the subsequent development of endoscopic ultrasound-guided drainage (EUS-GD) procedures, the available options for drainage in symptomatic PFCs included surgical drainage, percutaneous drainage using radiological guidance and conventional endoscopic transmural drainage. In recent years, it has gradually been recog-nized that, due to its lower morbidity rate compared to the surgical and percutaneous approaches, endoscopic treatment may be the preferred first-line approach for managing symptomatic PFCs. Endoscopic ultrasound-guided drainage has the following advantages, when compared to other alternatives such as surgical, per-cutaneous and non-EUS-guided endoscopic drainage.EUS-GD is less invasive than surgery and therefore does not require general anesthesia. The morbidity rate is lower, recovery is faster and the costs are lower. EUS-GD can avoid local complications related to per-cutaneous drainage. Because the endoscope is placed adjacent to the fluid collection, it can have direct ac-cess to the fluid cavity, unlike percutaneous drainage which traverses the abdominal wall. Complications such as bleeding, inadvertent puncture of adjacent viscera, secondary infection and prolonged periods of drainage with resultant pancreatico-cutaneous fistulae may be avoided. The only difference between EUS and non-EUS drainage is the initial step, namely, gaining access to the pancreatic fluid collection. All the sub-sequent steps are similar, i.e., insertion of guide-wires with fluoroscopic guidance, balloon dilatation of the cystogastrostomy and insertion of transmural stents or nasocystic catheters. Wi 展开更多
关键词 ENDOSCOPIC ULTRASOUND-GUIDED drainage PANCREATIC FLUID COLLECTIONS PSEUDOCYSTS PANCREATIC abscesses Infected necrosis
下载PDF
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B:Results of an open,controlled trial 被引量:10
5
作者 M. Francesca Jaboli Carlo fabbri +12 位作者 Stefania Liva Francesco Azzaroli Giovanni Nigro Silvia Giovanelli Francesco Ferrara Anna Miracolo Sabrina Marchetto Marco Montagnani Antonio Colecchia Davide Festi Letizia Bacchi Reggiani Enrico Roda Giuseppe Mazzella 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第7期1491-1495,共5页
AIM: To investigate the safety and efficacy of long-term combination therapy with alpha interferon and lamivudine in non-responsive patients with anti-HBe-positive chronic hepatitis B.METHODS: 34 patients received com... AIM: To investigate the safety and efficacy of long-term combination therapy with alpha interferon and lamivudine in non-responsive patients with anti-HBe-positive chronic hepatitis B.METHODS: 34 patients received combination treatment (1 month lamivudine, 12 month lamivudine+interferon, 6month lamivudine), 24 received lamivudine (12 months),24 received interferon (12 months). Interferon was administered at 6 MU tiw and lamivudine at 100 mg orally once daily. Patients were followed up for 6 months after treatment.RESULTS: At the end of treatment, HBV DNA negativity rates were 88 % with lamivudine+interferon, 99 % with lamivudine and 55 % with interferon, (P=0.004, combination therapy vs. interferon, and P=0.001 lamivudine vs.interferon), and serum transaminase normalization rates were 84 %, 91% and 53 % (P=0.01 combination therapy vs. interferon, and P=0.012 lamivudine vs. interferon). Six months later, HBV DNA negativity rates were 44 % with lamivudine+interferon, 33 % with lamivudine and 25 % with interferon, and serum transaminase normalization rates were 61%, 42 % and 45 %, respectively, without statistical significance. No YMDD variants were observed with lamivudine+interferon (vs. 12 % with lamivudine). The combination therapy appeared to be safe. CONCLUSION: Although viral clearance and transaminase normalization are slower with long-term lamivudine+interferon than that with lamivudine alone, the combination regimen seems to provide more lasting benefits and to protect against the appearance of YMDD variants. Studies with other regimens regarding sequence and duration are needed. 展开更多
关键词 ADULT Antiviral Agents DOSAGE Drug Therapy Combination FEMALE Hepatitis B Chronic Humans INTERFERON-ALPHA LAMIVUDINE Male Middle Aged Reverse Transcriptase Inhibitors Treatment Outcome
下载PDF
Is the pancreas affected in patients with septic shock?——a prospective study 被引量:13
6
作者 Raffaele Pezzilli Alessandra Barassi +5 位作者 Andrea Imbrogno Dario fabbri Antonina Pigna Antonio M.Morselli-Labate Roberto Corinaldesi Gianvico Melzi d'Eril 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第2期191-195,共5页
BACKGROUND:Hyperamylasemia can be observed anecdotally during the course of severe sepsis or septic shock.This study aimed to investigate the possibility of pancreatic involvement in patients with septic shock using s... BACKGROUND:Hyperamylasemia can be observed anecdotally during the course of severe sepsis or septic shock.This study aimed to investigate the possibility of pancreatic involvement in patients with septic shock using serum pancreatic enzyme determinations and imaging techniques in 21 consecutive patients with septic shock and 21 healthy subjects as controls. METHODS:The serum activity of pancreatic amylase and lipase was assayed initially in all subjects and 24 and 48 hours after the initial observation in the 21 patients with septic shock All patients also underwent radiological examination to detect pancreatic abnormalities. RESULTS:The serum activity of pancreatic amylase was significantly higher in the 21 patients with septic shock than in the 21 control subjects during the study period while the serum activity of lipase was similar to that of the control subjects.Amylase and lipase serum activity did not significantly changed throughout the study period in the 21 patients with septic shock.None of the patients with pancreatic hyperenzymemia had clinical signs or morphological alterations compatible with acute pancreatitis CONCLUSION:The presence of pancreatic hyperenzymemia in septic shock patients is not a biochemical manifestation of acute pancreatic damage,and the management of these patients should be dependent on the clinical situation and not merely the biochemical results. 展开更多
关键词 AMYLASE LIPASE clinical medicine shock SEPSIS systemic inflammatory response syndrome
下载PDF
Asthma and gastroesophageal reflux disease: Effect of long-term pantoprazole therapy 被引量:10
7
作者 Calabrese Carlo fabbri Anna +3 位作者 Areni Alessandra Scialpi Carlo Zahlane Desiree Di Febo Giulio 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第48期7657-7660,共4页
AIM: To define the prevalence of gastroesophageal reflux disease (GERD) in mild persistent asthma and to value the effect of pantoprazole therapy on asthmatic symptoms.METHODS: Seven of thirty-four asthmatic patie... AIM: To define the prevalence of gastroesophageal reflux disease (GERD) in mild persistent asthma and to value the effect of pantoprazole therapy on asthmatic symptoms.METHODS: Seven of thirty-four asthmatic patients without GERD served as the non-GERD control group. Twenty-seven of thirty-four asthmatic patients had GERD (7/27 also had erosive esophagitis, sixteen of them presented GERD symptoms. An upper gastrointestinal endoscopy was performed in all the subjects to obtain five biopsy specimens from the lower 5 cm of the esophagus. Patients were considered to have GERD when they had a dilation of intercellular space (DIS)〉0.74 μm at transmission electron microscopy. Patients with GERD were treated with pantoprazole, 80 mg/day. Forced expiratory volume in one second (FEV1) was performed at entry and after 6 mo of treatment. Asthmatic symptoms were recorded. The required frequency of inhaling rapid acting β2-agonists was self-recorded in the patients' diaries.RESULTS: Seven symptomatic patients presented erosive esophagitis. Among the 18 asymptomatic patients, 11 presented DIS, while all symptomatic patients showed ultrastructural esophageal damage. Seven asymptomatic patients did not present DIS. At entry the mean of FEV1 was 1.91 L in symptomatic GERD patients and 1.88 L in asymptomatic GERD patients. After the treatment, 25 patients had a complete recovery of DIS and reflux symptoms. Twenty-three patients presented a regression of asthmatic symptoms with normalization of FEV1. Four patients reported a significant improvement of symptoms and their FEV1 was over 80%.CONCLUSION: GERD is a highly prevalent condition in asthma patients. Treatment with pantoprazole (80 mg/day) determines their improvement and complete regression. 展开更多
关键词 ASTHMA Gastroesophageal reflux disease PANTOPRAZOLE NERD ERD Dilated intercellular spaces TEN
下载PDF
Microbiota-gut-brain axis and its affect inflammatory bowel disease:Pathophysiological concepts and insights for clinicians 被引量:9
8
作者 Emanuele Sinagra Erika Utzeri +3 位作者 Gaetano Cristian Morreale Carlo fabbri Fabio Pace Andrea Anderloni 《World Journal of Clinical Cases》 SCIE 2020年第6期1013-1025,共13页
Despite the bi-directional interaction between gut microbiota and the brain not being fully understood,there is increasing evidence arising from animal and human studies that show how this intricate relationship may f... Despite the bi-directional interaction between gut microbiota and the brain not being fully understood,there is increasing evidence arising from animal and human studies that show how this intricate relationship may facilitate inflammatory bowel disease(IBD)pathogenesis,with consequent important implications on the possibility to improve the clinical outcomes of the diseases themselves,by acting on the different components of this system,mainly by modifying the microbiota.With the emergence of precision medicine,strategies in which patients with IBD might be categorized other than for standard gut symptom complexes could offer the opportunity to tailor therapies to individual patients.The aim of this narrative review is to elaborate on the concept of the gutbrain-microbiota axis and its clinical significance regarding IBD on the basis of recent scientific literature,and finally to focus on pharmacological therapies that could allow us to favorably modify the function of this complex system. 展开更多
关键词 IRRITABLE BOWEL syndrome Inflammatory BOWEL disease Gut-brain AXIS Therapy
下载PDF
Using lysosomal membrane stability of haemocytes in Ruditapes philippinarum as a biomarker of cellular stress to assess contamination by caffeine, ibuprofen, carbamazepine and novobiocin 被引量:8
9
作者 Gabriela V. Aguirre-Martínez Sara Buratti +2 位作者 Elena fabbri Angel T. DelValls M. Laura Martín-Díaz 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2013年第7期1408-1418,共11页
Although pharmaceuticals have beendetected in the environment only in the range from ng/L to μg/L, it has beendemonstrated that they can adversely affect the health status of aquatic organisms. Lysosomal membrane sta... Although pharmaceuticals have beendetected in the environment only in the range from ng/L to μg/L, it has beendemonstrated that they can adversely affect the health status of aquatic organisms. Lysosomal membrane stability (LMS) has previously been applied as an indicator of cellularwell-being todetermine health status in bivalve mussels. The objective of this study is to evaluate LMS in Ruditapes philippinarum haemolymph using the neutral red retention assay (NRRA). Clamswere exposed in laboratory conditions to caffeine (0.1, 5, 15, 50 μg/L), ibuprofen (0.1, 5, 10, 50 μg/L), carbamazepine and novobiocin (both at 0.1, 1, 10, 50 μg/L) for35days. Results show adose-dependent effect of the pharmaceuticals. The neutral red retention time measured at the end of the bioassaywas significantly reduced by 50% after exposure to environmental concentrations (p 〈 0.05) (caffeine = 15 μg/L; ibuprofen = 10 μg/L; carbamazepine = 1 μg/L and novobiocin = 1 μg/L), compared to controls. Clams exposed to these pharmaceuticalswere considered to present adiminished health status (retention time 〈45 min), significantlyworse than controls (96 min) (p 〈 0.05). The predicted no environmental effect concentration (PNEC) results showed that these pharmaceuticals are very toxic at the environmental concentrations tested. Measurement of the alteration of LMS has been found to be a sensitive technique that enables evaluation of the health status of clams after exposure to pharmaceuticals under laboratory conditions, thus representing a robust Tier-1 screening biomarker. 展开更多
关键词 neutral red pharmaceuticals bioassay HAEMOLYMPH bivalves health status Manila clam
原文传递
Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind 被引量:8
10
作者 Marco Infante Martina Leoni +1 位作者 Massimiliano Caprio Andrea fabbri 《World Journal of Diabetes》 SCIE 2021年第7期916-931,共16页
To date,metformin remains the first-line oral glucose-lowering drug used for the treatment of type 2 diabetes thanks to its well-established long-term safety and efficacy profile.Indeed,metformin is the most widely us... To date,metformin remains the first-line oral glucose-lowering drug used for the treatment of type 2 diabetes thanks to its well-established long-term safety and efficacy profile.Indeed,metformin is the most widely used oral insulinsensitizing agent,being prescribed to more than 100 million people worldwide,including patients with prediabetes,insulin resistance,and polycystic ovary syndrome.However,over the last decades several observational studies and meta-analyses have reported a significant association between long-term metformin therapy and an increased prevalence of vitamin B12 deficiency.Of note,evidence suggests that long-term and high-dose metformin therapy impairs vitamin B12 status.Vitamin B12(also referred to as cobalamin)is a water-soluble vitamin that is mainly obtained from animal-sourced foods.At the cellular level,vitamin B12 acts as a cofactor for enzymes that play a critical role in DNA synthesis and neuroprotection.Thus,vitamin B12 deficiency can lead to a number of clinical consequences that include hematologic abnormalities(e.g.,megaloblastic anemia and formation of hypersegmented neutrophils),progressive axonal demyelination and peripheral neuropathy.Nevertheless,no definite guidelines are currently available for vitamin B12 deficiency screening in patients on metformin therapy,and vitamin B12 deficiency remains frequently unrecognized in such individuals.Therefore,in this“field of vision”article we propose a list of criteria for a cost-effective vitamin B12 deficiency screening in metformin-treated patients,which could serve as a practical guide for identifying individuals at high risk for this condition.Moreover,we discuss additional relevant topics related to this field,including:(1)The lack of consensus about the exact definition of vitamin B12 deficiency;(2)The definition of reliable biomarkers of vitamin B12 status;(3)Causes of vitamin B12 deficiency other than metformin therapy that should be identified promptly in metformin-treated patients for a proper differential diagnosis;an 展开更多
关键词 METFORMIN Vitamin B12 deficiency Metformin-induced cobalamin deficiency Diabetes Type 2 diabetes PREDIABETES Screening criteria NEUROPATHY ANEMIA
下载PDF
Pancreatic ductal adenocarcinoma screening:New perspectives 被引量:8
11
作者 Raffaele Pezzilli Dario fabbri Andrea Imbrogno 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第36期4973-4977,共5页
Pancreatic ductal adenocarcinoma accounts for more than 90% of all pancreatic cancers and its incidence has increased significantly worldwide.Patients with pancreatic ductal adenocarcinoma have a poor outcome and more... Pancreatic ductal adenocarcinoma accounts for more than 90% of all pancreatic cancers and its incidence has increased significantly worldwide.Patients with pancreatic ductal adenocarcinoma have a poor outcome and more than 95% of the people affected die from the disease within 12 mo after diagnosis.Surgery is the first-line treatment in the case of resectable neoplasm,but only 20% of patients are candidates for this approach.One of the reasons there are few candidates for surgery is that,during the early phases of the disease,the symptoms are poor or non-specific.Early diagnosis is of crucial importance to improve patient outcome;therefore,we are looking for a good screening test.The screening test must identify the disease in an early stage in order to be effective;having said this,a need exists to introduce the concept of "early" ductal adenocarcinoma.It has been reported that at least five additional years after the occurrence of the initiating mutation are required for the acquisition of metastatic ability of pancreatic adenocarcinoma and patients die an average of two years thereafter.We have reviewed the most recent literature in order to evaluate the present and future perspectives of screening programs of this deadly disease. 展开更多
关键词 Pancreatic neoplasms Study population PREVENTION THERAPEUTICS
下载PDF
日本南海海槽俯冲增生楔前缘的构造变形特征 被引量:6
12
作者 李春峰 苏新 +5 位作者 姜涛 Ujiie K fabbri O Yamaguchi A Chester F M Kimura G 《地球科学进展》 CAS CSCD 北大核心 2010年第2期203-211,共9页
对增生楔不同压力—温度条件下的构造变形、流体活动、沉积特征、岩石物性和化学组成等多方面的直接观测,可以帮助分析俯冲带地震的蕴育和发生的环境与机理。通过参加IODP的日本南海海槽发震带研究项目(NanTroSEIZE)第一阶段316航次所... 对增生楔不同压力—温度条件下的构造变形、流体活动、沉积特征、岩石物性和化学组成等多方面的直接观测,可以帮助分析俯冲带地震的蕴育和发生的环境与机理。通过参加IODP的日本南海海槽发震带研究项目(NanTroSEIZE)第一阶段316航次所收集到的大量第一手数据和资料,分别在4个站位上(C0004,C0006,C0007,C0008)对日本南海海槽增生楔前缘岩芯尺度上的构造变形进行了详细分析,并且讨论了岩芯尺度上的构造变形与增生楔中大尺度的非序列分支逆冲断层和前缘逆冲断层的构造变形之间的关系。发现逆冲变形不是只在大尺度的逆冲断层面上进行,而是弥散分布在主逆冲断层面、次级逆冲断层面以及断层面之间的更小的尺度上。小尺度构造的倾向与大尺度断层的倾向有较好的一致性,表明它们是在相同的应力场下所形成的。在增生楔浅部高角度的正断层比较发育,显示张性应力场特征,同时所获得的岩芯尺度上的地层倾角较大并倾向与反射地震以及区域地质分析结果非常吻合,而在深部,特别是在大尺度逆冲断层发育带附近,各种类型的断层、滑移变形带、节理等非常普遍,同时层理与劈理的产状的复杂变化更多地受控于复杂的逆冲断层带的作用。 展开更多
关键词 日本南海海槽 增生楔 NANTROSEIZE IODP 构造变形 岩芯
原文传递
变湿度条件下生土材料持水特性及气态水迁移效应试验研究 被引量:4
13
作者 徐龙飞 翁效林 +3 位作者 张爱军 赵高文 WONG Henry fabbri Antonin 《岩土力学》 EI CAS CSCD 北大核心 2021年第9期2489-2498,共10页
湿度变化诱发气态水迁移,进而对生土的变形和强度产生重要影响。研究变湿度条件下生土材料持水特性及气态水迁移效应是揭示服役期生土结构病害孕育机制的关键。针对法国里昂地区两种生土建筑材料,采用两种试验方法,即饱和盐溶液法和动... 湿度变化诱发气态水迁移,进而对生土的变形和强度产生重要影响。研究变湿度条件下生土材料持水特性及气态水迁移效应是揭示服役期生土结构病害孕育机制的关键。针对法国里昂地区两种生土建筑材料,采用两种试验方法,即饱和盐溶液法和动态水蒸气吸附法开展等温吸湿试验,分析生土持水特性;通过气态水迁移效应试验,探究生土试样底部进气端和顶部出气端的湿度及水气相对压力变化规律,并对气态水迁移过程中生土试样变形进行分析。试验结果表明:两种方法测得生土吸湿曲线较为一致,可分为单层吸附阶段、多层吸附阶段和毛细凝聚阶段,并且土体持水能力随黏土颗粒活性增加而增强;在气态水迁移效应试验中,生土材料持水特性对出气端湿度与进气端水气相对压力影响明显,生土试样发生膨胀变形。 展开更多
关键词 生土 持水特性 气态水迁移 等温吸湿试验 膨胀变形
下载PDF
New oral agents for erectile dysfunction: what is changing in our practice? 被引量:4
14
作者 Antonio Aversa Andrea fabbri 《Asian Journal of Andrology》 SCIE CAS CSCD 2001年第3期175-179,共5页
Erectile dysfunction (ED) is a highly prevalent disorder affecting an estimated 152 million men worldwide and isassociated with a variety of behavioral risk factors, such as cigarette smoking and excessive alcohol con... Erectile dysfunction (ED) is a highly prevalent disorder affecting an estimated 152 million men worldwide and isassociated with a variety of behavioral risk factors, such as cigarette smoking and excessive alcohol consumption, aswell as numerous age - related medical conditions, notably type-2 diabetes mellitus and cardiovascular disease. A ratio-nal step - wise approach which includes comprehensive medical and sexual history, a focused physical examination andessential laboratory tests such as fasting glucose, lipid profile and testosterone assay is to be preferred. Current diagnos-tic work - up does not recommend any of the specialized tests which were previously considered mandatory-i. e. penilepharmacotesting, Duplex ultrasound and nocturnal penile tumescence. Hormonal replacement therapy is appropriate onlyin the hypogonadal male with ED. Prior to direct intervention, the physician should consider altering modifiable riskfactors or causes, although frequently insufficient to reverse ED completely. When indicated, oral therapy with newmolecules (phosphodiesterase inhibitors or apomorphine) is the first - line treatment for the majority of patients becauseof potential benefits and lack of invasiveness. (Asian J Androl 2001 Sep; 3: 175-179 ) 展开更多
关键词 erectile dysfunction oral medicine THERAPY phosphodiesterase inhibitors APOMORPHINE nitric oxide
下载PDF
JUNO sensitivity on proton decay p→νK^(+)searches 被引量:1
15
作者 Angel Abusleme Thomas Adam +113 位作者 Shakeel Ahmad Rizwan Ahmed Sebastiano Aiello Muhammad Akram 安丰鹏 安琪 Giuseppe Andronico Nikolay Anfimov Vito Antonelli Tatiana Antoshkina Burin Asavapibhop João Pedro Athayde Marcondes de André Didier Auguste Nikita Balashov Wander Baldini Andrea Barresi Davide Basilico Eric Baussan Marco Bellato Antonio Bergnoli Thilo Birkenfeld Sylvie Blin David Blum Simon Blyth Anastasia Bolshakova Mathieu Bongrand Clément Bordereau Dominique Breton Augusto Brigatti Riccardo Brugnera Riccardo Bruno Antonio Budano Mario Buscemi Jose Busto Ilya Butorov Anatael Cabrera Barbara Caccianiga 蔡浩 蔡啸 蔡严克 蔡志岩 Riccardo Callegari Antonio Cammi Agustin Campeny 曹传亚 曹国富 曹俊 Rossella Caruso Cédric Cerna 常劲帆 Yun Chang 陈平平 Po-An Chen 陈少敏 陈旭荣 Yi-Wen Chen 陈义学 陈羽 陈长 程捷 程雅苹 Alexey Chetverikov Davide Chiesa Pietro Chimenti Artem Chukanov Gérard Claverie Catia Clementi Barbara Clerbaux Selma Conforti Di Lorenzo Daniele Corti Flavio Dal Corso Olivia Dalager Christophe De La Taille 邓智 邓子艳 Wilfried Depnering Marco Diaz Xuefeng Ding 丁雅韵 Bayu Dirgantara Sergey Dmitrievsky Tadeas Dohnal Dmitry Dolzhikov Georgy Donchenko 董建蒙 Evgeny Doroshkevich Marcos Dracos Frédéric Druillole 杜然 杜书先 Stefano Dusini Martin Dvorak Timo Enqvist Heike Enzmann Andrea fabbri Ulrike Fahrendholz 范东华 樊磊 方建 方文兴 Marco Fargetta Dmitry Fedoseev Li-Cheng Feng 冯启春 Richard Ford Amélie Fournier 甘浩男 Feng Gao Alberto Garfagnini Arsenii Gavrikov Marco Giammarchi Agnese Giaz Nunzio Giudice 《Chinese Physics C》 SCIE CAS CSCD 2023年第11期7-22,共16页
The Jiangmen Underground Neutrino Observatory(JUNO)is a large liquid scintillator detector designed to explore many topics in fundamental physics.In this study,the potential of searching for proton decay in the p→νK... The Jiangmen Underground Neutrino Observatory(JUNO)is a large liquid scintillator detector designed to explore many topics in fundamental physics.In this study,the potential of searching for proton decay in the p→νK^(+)mode with JUNO is investigated.The kaon and its decay particles feature a clear three-fold coincidence signature that results in a high efficiency for identification.Moreover,the excellent energy resolution of JUNO permits suppression of the sizable background caused by other delayed signals.Based on these advantages,the detection efficiency for the proton decay via p→νK^(+)is 36.9%±4.9%with a background level of 0.2±0.05(syst)±0.2(stat)events after 10 years of data collection.The estimated sensitivity based on 200 kton-years of exposure is 9.6×1033 years,which is competitive with the current best limits on the proton lifetime in this channel and complements the use of different detection technologies. 展开更多
关键词 proton decay grand unified theories JUNO liquid scintillator detector
原文传递
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 被引量:3
16
作者 Carlo Calabrese Anna fabbri +5 位作者 Mauro Bortolotti Giovanna Cenacchi Scialpi Carlo Desiree Zahlane Mario Miglioli Giulio Di Febo 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第12期1876-1880,共5页
AIM: To value whether omeprazole could induce the healing of DIS and regression of symptoms in patients with DGER. METHODS: We enrolled 15 symptomatic patients with a pathological esophageal 24-h pH-metry and bilimetr... AIM: To value whether omeprazole could induce the healing of DIS and regression of symptoms in patients with DGER. METHODS: We enrolled 15 symptomatic patients with a pathological esophageal 24-h pH-metry and bilimetry. Patients underwent endoscopy and biopsies were taken from the distal esophagus. Specimens were analyzed at histology and transmission electron microscopy (TEM). Patients were treated with omeprazole 40 mg/d for 3 mo and then endoscopy with biopsies was repeated. Patients with persistent heartburn and/or with an incomplete recovery of DIS were treated for 3 more months and endoscopy with biopsies was performed. RESULTS: Nine patients had a non-erosive reflux disease at endoscopy (NERD) while 6 had erosive esophagitis (ERD). At histology, of the 6 patients with erosive esophagitis, 5 had mild esophagitis and 1 moderate esophagitis. No patients with NERD showed histological signs of esophagitis. After 3 mo of therapy, 13/15 patients (86.7%,P<0.01) showed a complete recovery of DIS and disappearance of heartburn. Of the 2 patients treated for 3 more months, complete recovery of DIS and heartburn were achieved in one. CONCLUSION: Three or 6 mo of omeprazole therapy led to a complete regression of the ultrastructural esophageal damage in 86.7% and in 93% of patients with DGER, NERD and ERD respectively. The ultrastructural recovery of the epithelium was accompanied by regression of heartburn in all cases. 展开更多
关键词 Duodenogastroesophageal reflux Gastroeso phageal reflux disease Transmission Electron Microscopy Dilated Intercellular Spaces Non-erosive reflux disease
下载PDF
Current status of peroral cholangioscopy in biliary tract diseases 被引量:4
17
作者 Stefania Ghersi Lorenzo Fuccio +2 位作者 Marco Bassi Carlo fabbri Vincenzo Cennamo 《World Journal of Gastrointestinal Endoscopy》 CAS 2015年第5期510-517,共8页
Peroral cholangioscopy(POC) is an important tool for the management of a selected group of biliary diseases. Because of its direct visualization, POC allows targeted diagnostic and therapeutic procedures. POC can be p... Peroral cholangioscopy(POC) is an important tool for the management of a selected group of biliary diseases. Because of its direct visualization, POC allows targeted diagnostic and therapeutic procedures. POC can be performed using a dedicated cholangioscope that is advanced through the accessory channel of a duodenoscope or via the insertion of a small-diameter endoscope directly into the bile duct. POC was first described in the 1970 s, but the use of earlier generation devices was substantially limited by the cumbersome equipment setup and high repair costs. For nearly ten years, several technical improvements, including the single-operator system, high-quality images, the development of dedicated accessories and the increased size of the working channel, have led to increased diagnostic accuracy, thus assisting in the differentiation of benign and malignant intraductal lesions, targeting biopsies and the precise delineation of intraductal tumor spread before surgery. Furthermore, lithotripsy of difficult bile duct stones, ablative therapies for biliary malignancies and direct biliary drainage can be performed under POC control. Recent developments of new types of conventional POCs allow feasible, safe and effective procedures at reasonable costs. In the current review, we provide an updated overview of POC, focusing our attention on the main current clinical applications and on areas for future research. 展开更多
关键词 Peroral CHOLANGIOSCOPY BILIARY TRACT disease Direct visualization INDETERMINATE BILIARY STRICTURES Bileduct STONES
下载PDF
The outcomes and safety of patients undergoing endoscopic retrograde cholangiopancreatography combining a single-use cholangioscope and a single-use duodenoscope:A multicenter retrospective international study
18
作者 Alessandro Fugazza Matteo Colombo +20 位作者 Michel Kahaleh V.Raman Muthusamy Bick Benjamin Wim Laleman Carmelo Barbera Carlo fabbri Jose Nieto Abed Al-Lehibi Mohan Ramchandani Amy Tyberg Haroon Shahid Avik Sarkar Dean Ehrlich Stuart Shermand Cecilia Binda Marco Spadaccini Andrea Iannone Kareem Khalaf Nageshwar Reddy Andrea Anderloni Alessandro Repici 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2024年第1期71-76,共6页
Background: Duodenoscope-related multidrug-resistant organism(MDRO) infections raise concerns. Disposable duodenoscopes have been recently introduced in the market and approved by regulatory agencies with the aim to r... Background: Duodenoscope-related multidrug-resistant organism(MDRO) infections raise concerns. Disposable duodenoscopes have been recently introduced in the market and approved by regulatory agencies with the aim to reduce the risk of endoscopic retrograde cholangiopancreatography(ERCP) associated infections. The aim of this study was to evaluate the outcome of procedures performed with single-use duodenoscopes in patients with clinical indications to single-operator cholangiopancreatoscopy. Methods: This is a multicenter international, retrospective study combining all patients who underwent complex biliopancreatic interventions using the combination of a single-use duodenoscope and a single-use cholangioscope. The primary outcome was technical success defined as ERCP completion for the intended clinical indication. Secondary outcomes were procedural duration, rate of cross-over to reusable duodenoscope, operator-reported satisfaction score(1 to 10) on performance rating of the single-use duodenoscope, and adverse event(AE) rate. Results: A total of 66 patients(26, 39.4% female) were included in the study. ERCP was categorized according to ASGE ERCP grading system as 47(71.2%) grade 3 and 19(28.8%) grade 4. The technical success rate was 98.5%(65/66). Procedural duration was 64(interquartile range 15-189) min, cross-over rate to reusable duodenoscope was 1/66(1.5%). The satisfaction score of the single-use duodenoscope classified by the operators was 8.6 ± 1.3 points. Four patients(6.1%) experienced AEs not directly related to the single-use duodenoscope, namely 2 post-ERCP pancreatitis(PEP), 1 cholangitis and 1 bleeding.Conclusions: Single-use duodenoscope is effective, reliable and safe even in technically challenging procedures with a non-inferiority to reusable duodenoscope, making these devices a viable alternative to standard reusable equipment. 展开更多
关键词 Single-operator cholangioscopy Single-use duodenoscope Endoscopic retrograde CHOLANGIOPANCREATOGRAPHY Indeterminate biliary stricture Difficult biliary stones
下载PDF
Time-Resolved Oxidation State Changes Are Key to Elucidating the Bifunctionality of Perovskite Catalysts for Oxygen Evolution and Reduction
19
作者 Casey E.Beall Emiliana fabbri +7 位作者 Adam H.Clark Vivian Meier Nur Sena Yüzbasi Benjamin H.Sj∅lin Ivano E.Castelli Dino Aegerter Thomas Graule Thomas J.Schmidt 《Energy & Environmental Materials》 SCIE EI CAS CSCD 2024年第5期292-300,共9页
In a unified regenerative fuel cell(URFC)or reversible fuel cell,the oxygen bifunctional catalyst must switch reversibly between the oxygen reduction reaction(ORR),fuel cell mode,and the oxygen evolution reaction(OER)... In a unified regenerative fuel cell(URFC)or reversible fuel cell,the oxygen bifunctional catalyst must switch reversibly between the oxygen reduction reaction(ORR),fuel cell mode,and the oxygen evolution reaction(OER),electrolyzer mode.However,it is often unclear what effect alternating between ORR and OER has on the electrochemical behavior and physiochemical properties of the catalyst.Herein,operando X-ray absorption spectroscopy(XAS)is utilized to monitor the continuous and dynamic evolution of the Co,Mn,and Fe oxidation states of perovskite catalysts Ba_(0.5)Sr_(0.5)Co_(0.8)Fe_(0.2)O_(3-δ)(BSCF)and La_(0.4)Sr_(0.6)MnO_(3-δ)(LSM),while the potential is oscillated between reducing and oxidizing potentials with cyclic voltammetry.The results reveal the importance of investigating bifunctional catalysts by alternating between fuel cell and electrolyzer operation and highlight the limitations and challenges of bifunctional catalysts.It is shown that the requirements for ORR and OER performance are divergent and that the oxidative potentials of OER are detrimental to ORR activity.These findings are used to give guidelines for future bifunctional catalyst design.Additionally,it is demonstrated how sunlight can be used to reactivate the ORR activity of LSM after rigorous cycling. 展开更多
关键词 BSCF LSM OER ORR XAS
下载PDF
内镜超声治疗及其系统回顾 被引量:3
20
作者 龚雪屹 汪谦 +2 位作者 fabbri C Luigiano C Lisotti A 《中华普通外科学文献(电子版)》 2014年第6期57-64,共8页
当代减少外科手术治疗和介入辐射的理念有力地促进了目前内镜超声治疗手段的发展水平。内镜超声已经应用于胰腺积液引流,坏死灶切除,胆管造影及引流,胰管造影及引流,胆囊引流,腹腔及盆腔引流,腹腔丛阻滞及消融,囊肿切除,血管介入,抗肿... 当代减少外科手术治疗和介入辐射的理念有力地促进了目前内镜超声治疗手段的发展水平。内镜超声已经应用于胰腺积液引流,坏死灶切除,胆管造影及引流,胰管造影及引流,胆囊引流,腹腔及盆腔引流,腹腔丛阻滞及消融,囊肿切除,血管介入,抗肿瘤药物导入,校准放置放疗及抵近放射治疗等领域。然而该技术对操作要求较高,操作人员必须同时精通内镜及内镜介入操作,如内镜下逆行胰胆管造影术(ERCP)及胃肠道支架放置等技术。本文着眼于近20年内发表的所有相关文献进行系统回顾,在循证医学的基础上对现行发表文章进行相对客观的评价,力求推动该领域内的进一步发展。 展开更多
关键词 内窥镜下超声 胰腺假性囊肿引流术 腹腔神经丛消融术 循证医学等级 细针注射术
原文传递
上一页 1 2 4 下一页 到第
使用帮助 返回顶部